ClinVar Miner

Submissions for variant NM_014679.5(CEP57):c.373C>T (p.His125Tyr)

gnomAD frequency: 0.00001  dbSNP: rs751973626
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000649344 SCV000771171 uncertain significance Mosaic variegated aneuploidy syndrome 2 2024-03-06 criteria provided, single submitter clinical testing This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 125 of the CEP57 protein (p.His125Tyr). This variant is present in population databases (rs751973626, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with CEP57-related conditions. ClinVar contains an entry for this variant (Variation ID: 539587). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CEP57 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV004972810 SCV005561106 uncertain significance Inborn genetic diseases 2024-11-24 criteria provided, single submitter clinical testing The p.H125Y variant (also known as c.373C>T), located in coding exon 3 of the CEP57 gene, results from a C to T substitution at nucleotide position 373. The histidine at codon 125 is replaced by tyrosine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear.
Fulgent Genetics, Fulgent Genetics RCV000649344 SCV005631471 uncertain significance Mosaic variegated aneuploidy syndrome 2 2024-04-10 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.